Chemotherapy
Research on chemotherapy detailed by scientists at JMI Laboratories Inc.
Published in Lab Business Week, March 25th, 2007
A report, "Re-evaluation of the role of broad-spectrum cephalosporins against staphylococci by applying contemporary in-vitro results and pharmacokinetic-pharmacodynamic principles," is newly published data in Journal of Chemotherapy. "The potency of cefepime, ceftriaxone, and ceftazidime was assessed by CLSI broth microdilution methods against 41,644 S. aureus (63.2% oxacillin-susceptible) and 14,266 coagulase-negative staphylococci (CoNS; 22.2% oxacillin-susceptible) through the SENTRY Antimicrobial Surveillance Program database (1998-2004). Using normal volunteer pharmacokinetic data and a linear intermittent intravenous infusion model, and an animal-derived...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-03-25)
More Articles from Lab Business Week
- Auriga Laboratories, Inc.
Auriga Laboratories Promotes Alan Roberts to Chief Scientific Officer - Bio-Rad Laboratories
BIO-RAD'S RECENT APPOINTMENT OF NEW BOARD MEMBER BRINGS THE COMPANY INTO COMPLIANCE WITH THE AMERICAN STOCK EXCHANGE - Brain Research
Scientists at Gorlaeus Laboratories discuss research in brain research - Breast Cancer
US LABS Meets the ASCO/CAP Her-2 Guidelines - Cancer
Research on cancer described by scientists at Cold Spring Harbor Laboratory - Cancer Therapy
New cancer therapy findings from Abbott Laboratories described - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
